Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

Diabetes in China

Diabetes in China

Published in PME, August 2011 By Marc Yates, Director, and Julie Denny, Director

Study investigated patients’ attitudes and practices in managing their disease to provide greater insight into this escalating problem ChallengesCurrent statistics indicate that over 43 million people in China have been diagnosed with type 2 diabetes and that figure is set to continue to rise with the increased urbanisation of the country and the adoption of more Western lifestyles. This means that China is a huge growth market for diabetes brand owners. With no formal referral process, patients are free to see whichever doctor they choose, as long as they can afford it, which results in lots of doctor-hopping and selection based on word-of-mouth. Hospitals rely on revenue generated by patients, many of whom pay a proportion of their consultation and treatment costs, so patients are looking for an effective treatment at a price they can afford. The problem for the pharmaceutical industry was to uncover greater understanding of Chinese patients. SolutionThe research study ‘Living with Diabetes’ was carried out by The Research Partnership in response to this need. Unlike many research studies, where the doctor provides information using patient medical forms, this study aimed to get a direct understanding of patients’ attitudes, behaviours, thoughts and feelings towards living with their…

read more »

  • Posted by Katrina Johnson
  • August 15, 2011
  • Articles

Patients with Rheumatoid Arthritis wait 18 months before going to see their doctor and 7 years to be treated with a biologic

Published in PharmaLive, August 2011 By Katrina Johnson, Director

Patients with Rheumatoid Arthritis wait 18 months before going to see their doctor and 7 years to be treated with a biologic A new research study published today reveals that patients wait 18 months after first experiencing any symptoms of Rheumatoid Arthritis (RA) before going to see their doctor. The study, which was carried out online amongst over 2,200 sufferers with moderate to severe RA from the US and 5 EU countries, also reveals that patients who have been diagnosed with RA wait an average of 7 years before their doctor starts treating them with a biologic. This is despite findings that show patients who are on a biologic treatment are happier with how their illness is being controlled, report a reduction in the severity of their symptoms, are better educated about RA and enjoy a better relationship with their doctor. Findings from the research suggest that pharmaceutical marketers working with RA brands need to do more to persuade doctors to move patients more quickly onto a biologic to improve satisfaction and prevent their condition worsening. Over half of patients (55%) not on a biologic have not discussed this option with their doctor. One in four (26%) patients with RA…

read more »

  • Posted by Julie Denny
  • August 8, 2011
  • Articles

RA patients "wait seven years before getting biologics"

RA patients "wait seven years before getting biologics"

Pharma Times Online, August 2011 By Julie Denny, Director

Patients wait 18 months after first experiencing any symptoms of rheumatoid arthritis (RA) before going to see their doctor, and they wait an average of seven years before their doctor starts treating with them a biologic drug, says a new study.This is despite findings which show that patients who are being treated with a biologic are happier about how their illness is being controlled, report a reduction in the severity of their symptoms, are better educated about RA and enjoy a better relationship with their doctor, according to the researchers.The study, which was carried out online amongst over 2,200 people in the US and five European Union (EU) nations who are suffering from moderate to severe RA, discovered that 55% of patients who are not being treated with a biologic had not discussed this option with their doctor. Moreover, 26% of the patients were found to have a related autoimmune disease such as psoriasis or irritable bowel syndrome (IBD), which could also be effectively treated with a biologic to reduce symptoms and slow progression, according to the report, which is published by global pharmaceutical research agency The Research Partnership.Related LinksBiosimilars: physicians cite concerns over supporting data Alternative biologics set to…

read more »